Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials

The data bolsters Eli Lilly's position in the budding weight loss drug market and establishes the company as a formidable competitor to Novo Nordisk.

from Health and Science https://ift.tt/K48yv93
https://ift.tt/aOiNjfm
https://ift.tt/zH4wc5Q